Cotton MF, Madhi SA, Luabeya AK, Tameris M, et al. Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial. Lancet Infect Dis 2022 Jun 27. pii: S1473-3099(22)00222.
PMID: 35772447